Search the collection

2 results for Nuyens,+Sarah

Sort by:

Sort by

Limit results to:

20 per page

2 results for Nuyens,+Sarah

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
Author / Creator:van den Bent, Martin J, Prof ; Tesileanu, C Mircea S, MD ; Wick, Wolfgang, Prof ; Sanson, Marc, Prof ; Brandes, Alba Ariela, MD ; Clement, Paul M, Prof ; Erridge, Sarah, MD ; Vogelbaum, Michael A, Prof ; Nowak, Anna K, Prof ; Baurain, Jean Français, Prof ; Mason, Warren P, Prof ; Wheeler, Helen, MD ; Chinot, Olivier L, Prof ; Gill, Sanjeev, MD ; Griffin, Matthew, FRCR ; Rogers, Leland, MD ; Taal, Walter, MD ; Rudà, Roberta, MD ; Weller, Michael, Prof ; McBain, Catherine, MD ; Reijneveld, Jaap, MD ; Enting, Roelien H, MD ; Caparrotti, Francesca, MD ; Lesimple, Thierry, MD ; Clenton, Susan, MSc ; Gijtenbeek, Anja, MD ; Lim, Elizabeth, MD ; Herrlinger, Ulrich, Prof ; Hau, Peter, Prof ; Dhermain, Frederic, MD ; de Heer, Iris ; Aldape, Kenneth, MD ; Jenkins, Robert B, Prof ; Dubbink, Hendrikus Jan, PhD ; Kros, Johan M, Prof ; Wesseling, Pieter, Prof ; Nuyens, Sarah ; Golfinopoulos, Vassilis, MD ; Gorlia, Thierry, PhD ; French, Pim, PhD ; Baumert, Brigitta G, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2021-06, Vol.22 (6), p.813-823
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label in...
Author / Creator:van den Bent, Martin J ; Baumert, Brigitta ; Erridge, Sara C ; Vogelbaum, Michael A ; Nowak, Anna K ; Sanson, Marc ; Brandes, Alba Ariela ; Clement, Paul M ; Baurain, Jean Francais ; Mason, Warren P ; Wheeler, Helen ; Chinot, Olivier L ; Gill, Sanjeev ; Griffin, Matthew ; Brachman, David G ; Taal, Walter ; Rudà, Roberta ; Weller, Michael ; McBain, Catherine ; Reijneveld, Jaap ; Enting, Roelien H ; Weber, Damien C ; Lesimple, Thierry ; Clenton, Susan ; Gijtenbeek, Anja ; Pascoe, Sarah ; Herrlinger, Ulrich ; Hau, Peter ; Dhermain, Frederic ; van Heuvel, Irene ; Stupp, Roger ; Aldape, Ken ; Jenkins, Robert B ; Dubbink, Hendrikus Jan ; Dinjens, Winand N M ; Wesseling, Pieter ; Nuyens, Sarah ; Golfinopoulos, Vassilis ; Gorlia, Thierry ; Wick, Wolfgang ; Kros, Johan M
Publisher:England: Elsevier Ltd
Journal title:The Lancet (British edition), 2017-10, Vol.390 (10103), p.1645-1653
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

Export this record

Export record to excel

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label in...

Refine your search